This preview shows pages 1–3. Sign up to view the full content.
This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: Working Capital (5%) R&D (biotech startup) Sales (pharmaceutical) 3% Real Estate (1%) NFP (1/2%-2%) Qualitative Factors: Management Fraud Profit vs. Loss Debt Covenant Restrictions Change in Earnings Trend Affect of Error in B/S or I/S account Meeting analysts expectation Meeting or exceeding incentive goals...
View Full Document
- Fall '08